
Mainstay Medical
Innovative implantable neurostimulation system.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | $125m | Post IPO Equity | |
Total Funding | 000k |

KCK(exited)

Fountain Healthcare Partners(exited)

Sofinnova Partners(exited)

Seventure Partners(exited)

Capricorn Partners(exited)

IPF Partners(exited)

Ally Bridge Group(exited)

Oxford Finance(exited)

Quest for Growth(exited)

Armentum Partners(exited)
EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | - | 100 % | 70 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | - | (7934 %) | (4404 %) | (1690 %) |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | - | (8573 %) | (4687 %) | (2026 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | - | 1198 % | 520 % | 262 % |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.